ASX Announcements

NOX closes $4m capital raising for US subsidiary Nyrada Inc
Appendix 4C - quarterly
Section 708 Certificate
Appendix 3B
Section 708 Certificate
Appendix 3B
NOX receives FY17 R&D Tax Rebate
Kazia Therapeutics Ltd and Noxopharm Ltd
EOY Guidance on 2018 NOX66 Clinical Development Strategy
Section 708 Certificate